| Year |
Citation |
Score |
| 2014 |
Miguelez C, Morera-Herreras T, Torrecilla M, Ruiz-Ortega JA, Ugedo L. Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease. Frontiers in Neural Circuits. 8: 21. PMID 24672433 DOI: 10.3389/fncir.2014.00021 |
0.367 |
|
| 2014 |
Aristieta A, Morera-Herreras T, Ruiz-Ortega JA, Miguelez C, Vidaurrazaga I, Arrue A, Zumarraga M, Ugedo L. Modulation of the subthalamic nucleus activity by serotonergic agents and fluoxetine administration. Psychopharmacology. 231: 1913-24. PMID 24271033 DOI: 10.1007/s00213-013-3333-0 |
0.579 |
|
| 2011 |
Morera-Herreras T, Ruiz-Ortega JA, Linazasoro G, Ugedo L. Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats. Psychopharmacology. 214: 379-89. PMID 20959968 DOI: 10.1007/s00213-010-2043-0 |
0.568 |
|
| 2010 |
Morera-Herreras T, Ruiz-Ortega JA, Taupignon A, Baufreton J, Manuel I, Rodriguez-Puertas R, Ugedo L. Regulation of subthalamic neuron activity by endocannabinoids. Synapse (New York, N.Y.). 64: 682-98. PMID 20336631 DOI: 10.1002/syn.20778 |
0.397 |
|
| 2010 |
Morera-Herreras T, Ruiz-Ortega JA, Ugedo L. Two opposite effects of Delta(9)-tetrahydrocannabinol on subthalamic nucleus neuron activity: involvement of GABAergic and glutamatergic neurotransmission. Synapse (New York, N.Y.). 64: 20-9. PMID 19725112 DOI: 10.1002/syn.20701 |
0.551 |
|
| 2008 |
Morera-Herreras T, Ruiz-Ortega JA, Gómez-Urquijo S, Ugedo L. Involvement of subthalamic nucleus in the stimulatory effect of Delta(9)-tetrahydrocannabinol on dopaminergic neurons. Neuroscience. 151: 817-23. PMID 18164823 DOI: 10.1016/j.neuroscience.2007.11.016 |
0.506 |
|
| 2007 |
Torrecilla M, Ruiz-Ortega JA, Ugedo L, Pineda J. Excitatory regulation of noradrenergic neurons by L-arginine/nitric oxide pathway in the rat locus coeruleus in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology. 375: 337-47. PMID 17473915 DOI: 10.1007/s00210-007-0163-9 |
0.37 |
|
| 2006 |
Bilbao G, Ruiz-Ortega JA, Miguens N, Ulibarri I, Linazasoro G, Gómez-Urquijo S, Garibi J, Ugedo L. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment. Brain Research. 1084: 175-84. PMID 16574080 DOI: 10.1016/j.brainres.2006.02.052 |
0.468 |
|
| 2005 |
Artaiz I, Zazpe A, Innerárity A, Del Olmo E, DÃaz A, Ruiz-Ortega JA, Castro E, Pena R, Labeaga L, Pazos A, Orjales A. Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties. Psychopharmacology. 182: 400-13. PMID 16032410 DOI: 10.1007/s00213-005-0087-3 |
0.395 |
|
| 2003 |
Arrue A, Ruiz-Ortega JA, Ugedo L, Giralt MT. Short-term effects of 3,4-methylenedioximethamphetamine on noradrenergic activity in locus coeruleus and hippocampus of the rat. Neuroscience Letters. 337: 123-6. PMID 12536039 DOI: 10.1016/s0304-3940(02)01252-1 |
0.38 |
|
| 2002 |
Ruiz-Durántez E, Ruiz-Ortega JA, Pineda J, Ugedo L. Effect of agmatine on locus coeruleus neuron activity: possible involvement of nitric oxide. British Journal of Pharmacology. 135: 1152-8. PMID 11877321 DOI: 10.1038/sj.bjp.0704556 |
0.402 |
|
| 2000 |
Mateo Y, Ruiz-Ortega JA, Pineda J, Ugedo L, Meana JJ. Inhibition of 5-hydroxytryptamine reuptake by the antidepressant citalopram in the locus coeruleus modulates the rat brain noradrenergic transmission in vivo. Neuropharmacology. 39: 2036-43. PMID 10963747 DOI: 10.1016/S0028-3908(00)00041-1 |
0.489 |
|
| 1999 |
Ugedo L, Pineda J, Martín-Ruiz R, Ruiz-Ortega JA, Artigas F. Imidazoline-induced inhibition of firing rate of 5-HT neurons in rat dorsal raphe by modulation of extracellular 5-HT levels. Annals of the New York Academy of Sciences. 881: 365-8. PMID 10415938 DOI: 10.1111/j.1749-6632.1999.tb09382.x |
0.471 |
|
| 1998 |
Ugedo L, Pineda J, Ruiz-Ortega JA, MartÃn-Ruiz R. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study. British Journal of Pharmacology. 125: 1685-94. PMID 9886760 DOI: 10.1038/sj.bjp.0702255 |
0.454 |
|
| 1997 |
Ruiz-Ortega JA, Ugedo L. Activation of 5-HT1A receptors potentiates the clonidine inhibitory effect in the locus coeruleus. European Journal of Pharmacology. 333: 159-62. PMID 9314029 DOI: 10.1016/S0014-2999(97)01135-7 |
0.414 |
|
| 1997 |
Pineda J, Ruiz-Ortega JA, Ugedo L. Receptor reserve and turnover of alpha-2 adrenoceptors that mediate the clonidine-induced inhibition of rat locus coeruleus neurons in vivo. The Journal of Pharmacology and Experimental Therapeutics. 281: 690-8. PMID 9152374 |
0.451 |
|
| 1997 |
Ruiz-Ortega JA, Ugedo L. The stimulatory effect of clonidine on locus coeruleus neurons of rats with inactivated alpha 2-adrenoceptors: involvement of imidazoline receptors located in the nucleus paragigantocellularis. Naunyn-Schmiedeberg's Archives of Pharmacology. 355: 288-94. PMID 9050025 DOI: 10.1007/PL00004945 |
0.497 |
|
| 1996 |
Pineda J, Ruiz-Ortega JA, MartÃn-Ruiz R, Ugedo L. Agmatine does not have activity at alpha 2-adrenoceptors which modulate the firing rate of locus coeruleus neurones: an electrophysiological study in rat. Neuroscience Letters. 219: 103-6. PMID 8971790 DOI: 10.1016/S0304-3940(96)13180-3 |
0.394 |
|
| 1995 |
Pineda J, Ruiz-Ortega JA, Ugedo L, GarcÃa-Sevilla JA. The stimulatory effect of clonidine on locus coeruleus noradrenergic neurons through imidazoline receptors is modulated by excitatory amino acids. Annals of the New York Academy of Sciences. 763: 501-5. PMID 7677365 DOI: 10.1111/J.1749-6632.1995.Tb32441.X |
0.391 |
|
| 1995 |
Ruiz-Ortega JA, Ugedo L, Pineda J, GarcÃa-Sevilla JA. The stimulatory effect of clonidine through imidazoline receptors on locus coeruleus noradrenergic neurones is mediated by excitatory amino acids and modulated by serotonin. Naunyn-Schmiedeberg's Archives of Pharmacology. 352: 121-6. PMID 7477433 DOI: 10.1007/Bf00176764 |
0.515 |
|
| Show low-probability matches. |